Scott W. Morrison - 09 Sep 2021 Form 4 Insider Report for Global Blood Therapeutics, Inc.

Role
Director
Signature
/s/ Miguel Carrillo, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
09 Sep 2021
Net transactions value
-$145,003
Form type
4
Filing time
10 Sep 2021, 20:00:17 UTC
Previous filing
21 Jun 2021
Next filing
18 Oct 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GBT Common Stock Sale $145,003 -4,800 -61% $30.21 3,037 09 Sep 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the weighted average sale price of the shares sold ranging from $30.1800 to $30.2850 per share, inclusive. The Reporting Person will provide, upon request by the Issuer, a security holder of the Issuer, or the staff of the Securities and Exchange Commission, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.